Paul Krugman returns with a stark diagnosis: America is not just an outlier in healthcare spending, but a unique failure among advanced nations that spends the most while delivering the least. What makes this final installment of his series particularly urgent is its refusal to mourn the past; instead, it charts a pragmatic, politically savvy path forward for a post-MAGA era, arguing that the time for patchwork fixes has ended.
The Cost of Exceptionalism
Krugman opens by dismantling the myth that American healthcare is simply "different." He points to data showing that while U.S. performance was comparable to peers in 1980, a massive divergence occurred over the last four decades. "The gap in life expectancy is now more than 4 years," he notes, highlighting a human cost that extends far beyond economics. This isn't just about money; it's about a system that has actively worsened while others improved.
He contrasts this with the trajectory of the Affordable Care Act (ACA), which initially slowed rising costs and expanded coverage before recent political shifts threatened to unravel those gains. Krugman writes, "U.S. healthcare performance improved in terms of both coverage and cost after the Affordable Care Act... was enacted in 2010." Yet he is quick to temper optimism, describing the current system as "awkward and jerry-rigged," a complex add-on that failed to fix the underlying rot.
The argument gains weight when Krugman contextualizes this within our history of regulatory capture. He reminds readers that the U.S. has partial versions of every major healthcare model already in play, from socialized medicine in veterans' hospitals to single-payer for seniors. The problem isn't a lack of models; it's the political will to choose one. "Any effort to reform U.S. healthcare must take into account the way big money distorts both politics and policy to a greater extent than in any other wealthy nation," he asserts. This is a crucial framing: the barrier isn't technical feasibility, but the influence of entrenched interests.
Why Single-Payer Is Now the Only Viable Path
The core of Krugman's proposal is a shift in strategy. In 2010, he argued for the ACA as the only politically realistic option. Today, he argues that the political landscape has shifted enough to justify aiming higher. He rejects "socialized medicine"—where the government employs doctors and runs hospitals—as too vulnerable to mismanagement and underfunding, citing recent struggles in the UK's National Health Service. He also warns against a system centered on regulated private insurers, pointing to the corruption inherent in programs like Medicare Advantage.
"Given our history of political and regulatory capture by big money, it is profoundly unwise to make regulated private insurance the heart of our healthcare system."
Instead, Krugman champions a single-payer system with a public option, allowing Americans to buy into government coverage while letting private insurers compete on a level playing field. This approach leverages the administrative efficiency of government payment without forcibly eliminating private players. "Government healthcare coverage like the public option has significant advantages over private-sector coverage: much lower administrative costs... along with elimination of the profit-making incentives of denial of care," he explains.
This argument is bolstered by the success of existing single-payer components in the U.S., such as Medicare for those over 65. Krugman notes that despite attempts to privatize parts of it, these programs have been relatively successful in containing costs compared to projections. Critics might argue that a public option could lead to a two-tiered system where private insurers cherry-pick healthy patients, leaving the public option with sicker, more expensive enrollees. Krugman anticipates this, suggesting that over time, the lower costs of the public option will naturally draw people away from private plans, effectively outcompeting them rather than banning them.
The Changing Political Economy
Perhaps the most compelling part of Krugman's analysis is his assessment of the political moment. He acknowledges that passing the ACA in 2010 was a "political miracle" achieved only through extraordinary leadership and unique circumstances. But he argues that the public mood has fundamentally shifted.
The backlash against insurance companies, fueled by decades of premium hikes and coverage denials, has created fertile ground for reform. Krugman writes, "There is now very strong support for the idea that the U.S. government should, one way or another, ensure universal healthcare." This sentiment, combined with the failure of recent right-wing efforts to dismantle existing protections, suggests that a new administration could pursue comprehensive reform without the same political constraints as before.
He also touches on the specific vulnerabilities of the current system, referencing how the "Harry and Louise" ad campaign once successfully killed Clinton-era reforms by stoking fear. Today, however, the public has seen the benefits of expanded coverage firsthand. "The new law was highly unpopular for years," Krugman admits, but adds that it "gained strong public support only after Americans experienced its benefits." This historical context is vital; it suggests that education and experience are now allies of reformers, not enemies.
"Given the realities of America's money-driven politics, I believe that a single-payer system — rather than either direct government healthcare provision or regulated private-sector competition — is the reform most likely to succeed."
Bottom Line
Krugman's strongest move here is his evolution from defending compromise to demanding comprehensive change; he correctly identifies that the political window for incrementalism has closed, replaced by a public demand for systemic solutions. However, the biggest vulnerability in his argument remains the sheer scale of opposition from the insurance and pharmaceutical lobbies, which have proven capable of stalling even modest reforms. The reader should watch closely to see if the proposed "public option" can survive the inevitable legislative battles that will follow any attempt to implement it.